Hematological Malignancies in Al-Amal Oncology Unit, Aden
- 18 August 2011
- journal article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 28 (1) , 19-23
Abstract
The hematological malignancies (HM) are group of neoplasms that arise through malignant transformation of bone marrow derived cells. The great diversity seen in this group of disorders is a reflection of the complexity of normal hematopoiesis and the immune system. In the current study, the author retrospectively studied HM patients from 2008 to 2010, and compared with prevalence of solid tumor, and found HM represented one-fifth of all malignancies managed in the Oncology Unit, and lymphomas were the commonest HM.Keywords
This publication has 10 references indexed in Scilit:
- Five years cancer incidence in Aden Cancer Registry, Yemen (2002-2006).2010
- Battling the Hematological Malignancies: The 200 Years' WarThe Oncologist, 2008
- Epidemiology of hematological malignanciesAnnals of Oncology, 2007
- Newly diagnosed cases of hematologic malignancies in Sardinia in the early 2000: an estimation of their number, age and geographic distribution on the basis of a previous epidemiologic survey.2005
- Outcome of patients with hematological malignancies admitted to the intensive care unit with life-threatening complicationsSaudi Medical Journal, 2005
- Hematological malignancies in the island of Sardinia, 1974–1993: age and sex distributions and temporal changes in incidenceHematological Oncology, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphomaLeukemia, 2001
- Age and sex distributions of hematological malignancies in the U.K.Hematological Oncology, 1997
- Plasma cell dyscrasias: Current statusCritical Reviews in Oncology/Hematology, 1988